Preoperative Portal Vein Embolization for Hepatocellular Carcinoma: Consensus and Controversy

Overview

Journal World J Hepatol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2016 Mar 31

PMID 27028706

Citations 16

Authors

Taku Aoki

Keiichi Kubota

Affiliations

Soon will be listed here.

Abstract

Thirty years have passed since the first report of portal vein embolization (PVE), and this procedure is widely adopted as a preoperative treatment procedure for patients with a small future liver remnant (FLR). PVE has been shown to be useful in patients with hepatocellular carcinoma (HCC) and chronic liver disease. However, special caution is needed when PVE is applied prior to subsequent major hepatic resection in cases with cirrhotic livers, and volumetric analysis of the liver segments in addition to evaluation of the liver functional reserve before PVE is mandatory in such cases. Advances in the embolic material and selection of the treatment approach, and combined use of PVE and transcatheter arterial embolization/chemoembolization have yielded improved outcomes after PVE and major hepatic resections. A novel procedure termed the associating liver partition and portal vein ligation for staged hepatectomy has been gaining attention because of the rapid hypertrophy of the FLR observed in patients undergoing this procedure, however, application of this technique in HCC patients requires special caution, as it has been shown to be associated with a high morbidity and mortality even in cases with essentially healthy livers.

Citing Articles

Assessment of Segmentary Hypertrophy of Future Remnant Liver after Liver Venous Deprivation: A Single-Center Study.

Al Taweel B, Cassese G, Khayat S, Chazal M, Navarro F, Guiu B Cancers (Basel). 2024; 16(11).

PMID: 38893103 PMC: 11171007. DOI: 10.3390/cancers16111982.

Liver Venous Deprivation Versus Portal Vein Embolization Before Major Hepatectomy for Colorectal Liver Metastases: A Retrospective Comparison of Short- and Medium-Term Outcomes.

Cassese G, Troisi R, Khayat S, Benoudifa B, Quenet F, Guiu B J Gastrointest Surg. 2022; 27(2):296-305.

PMID: 36509901 PMC: 9744374. DOI: 10.1007/s11605-022-05551-2.

Prediction of left lobe hypertrophy after right lobe radioembolization of the liver using a clinical data model with external validation.

Theysohn J, Demircioglu A, Kleditzsch M, Ludwig J, Weber M, Umutlu L Sci Rep. 2022; 12(1):20718.

PMID: 36456637 PMC: 9715713. DOI: 10.1038/s41598-022-25077-6.

Neoadjuvant treatment strategies for hepatocellular carcinoma.

Xu L, Chen L, Zhang W World J Gastrointest Surg. 2022; 13(12):1550-1566.

PMID: 35070063 PMC: 8727178. DOI: 10.4240/wjgs.v13.i12.1550.

Oncological benefits of portal vein embolization for patients with hepatocellular carcinoma.

Beppu T, Yamamura K, Okabe H, Imai K, Hayashi H Ann Gastroenterol Surg. 2021; 5(3):287-295.

PMID: 34095718 PMC: 8164464. DOI: 10.1002/ags3.12414.

References

Yokoyama Y, Nagino M, Nimura Y . Mechanisms of hepatic regeneration following portal vein embolization and partial hepatectomy: a review. World J Surg. 2007; 31(2):367-74. DOI: 10.1007/s00268-006-0526-2. View

Shimamura T, Nakajima Y, Une Y, Namieno T, Ogasawara K, Yamashita K . Efficacy and safety of preoperative percutaneous transhepatic portal embolization with absolute ethanol: a clinical study. Surgery. 1997; 121(2):135-41. DOI: 10.1016/s0039-6060(97)90282-8. View

Pandanaboyana S, Bell R, Hidalgo E, Toogood G, Prasad K, Bartlett A . A systematic review and meta-analysis of portal vein ligation versus portal vein embolization for elective liver resection. Surgery. 2015; 157(4):690-8. DOI: 10.1016/j.surg.2014.12.009. View

Hayashi S, Baba Y, Ueno K, Nakajo M, Kubo F, Ueno S . Acceleration of primary liver tumor growth rate in embolized hepatic lobe after portal vein embolization. Acta Radiol. 2007; 48(7):721-7. DOI: 10.1080/02841850701424514. View

Nagino M, Nimura Y, Kamiya J, Kondo S, Uesaka K, Kin Y . Right or left trisegment portal vein embolization before hepatic trisegmentectomy for hilar bile duct carcinoma. Surgery. 1995; 117(6):677-81. DOI: 10.1016/s0039-6060(95)80012-3. View

Palavecino M, Chun Y, Madoff D, Zorzi D, Kishi Y, Kaseb A . Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: Perioperative outcome and survival. Surgery. 2009; 145(4):399-405. DOI: 10.1016/j.surg.2008.10.009. View

Schnitzbauer A, Lang S, Goessmann H, Nadalin S, Baumgart J, Farkas S . Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg. 2012; 255(3):405-14. DOI: 10.1097/SLA.0b013e31824856f5. View

Tanaka H, Hirohashi K, Kubo S, Shuto T, Higaki I, Kinoshita H . Preoperative portal vein embolization improves prognosis after right hepatectomy for hepatocellular carcinoma in patients with impaired hepatic function. Br J Surg. 2000; 87(7):879-82. DOI: 10.1046/j.1365-2168.2000.01438.x. View

Schadde E, Ardiles V, Slankamenac K, Tschuor C, Sergeant G, Amacker N . ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors compared with conventional-staged hepatectomies: results of a multicenter analysis. World J Surg. 2014; 38(6):1510-9. DOI: 10.1007/s00268-014-2513-3. View

10.

Hoekstra L, van Lienden K, Doets A, Busch O, Gouma D, van Gulik T . Tumor progression after preoperative portal vein embolization. Ann Surg. 2012; 256(5):812-7. DOI: 10.1097/SLA.0b013e3182733f09. View

11.

Schadde E, Ardiles V, Robles-Campos R, Malago M, Machado M, Hernandez-Alejandro R . Early survival and safety of ALPPS: first report of the International ALPPS Registry. Ann Surg. 2014; 260(5):829-36. DOI: 10.1097/SLA.0000000000000947. View

12.

Nagino M, Nimura Y, Kamiya J, Kondo S, Kanai M . Selective percutaneous transhepatic embolization of the portal vein in preparation for extensive liver resection: the ipsilateral approach. Radiology. 1996; 200(2):559-63. DOI: 10.1148/radiology.200.2.8685357. View

13.

Chen M, Hwang T, Hung C . Human liver regeneration after major hepatectomy. A study of liver volume by computed tomography. Ann Surg. 1991; 213(3):227-9. PMC: 1358332. DOI: 10.1097/00000658-199103000-00008. View

14.

Wakabayashi H, Ishimura K, Okano K, Izuishi K, Karasawa Y, Goda F . Is preoperative portal vein embolization effective in improving prognosis after major hepatic resection in patients with advanced-stage hepatocellular carcinoma?. Cancer. 2001; 92(9):2384-90. DOI: 10.1002/1097-0142(20011101)92:9<2384::aid-cncr1586>3.0.co;2-h. View

15.

Alvarez F, Ardiles V, de Santibanes M, Pekolj J, De Santibanes E . Associating liver partition and portal vein ligation for staged hepatectomy offers high oncological feasibility with adequate patient safety: a prospective study at a single center. Ann Surg. 2014; 261(4):723-32. DOI: 10.1097/SLA.0000000000001046. View

16.

Kokudo N, Tada K, Seki M, Ohta H, Azekura K, Ueno M . Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology. 2001; 34(2):267-72. DOI: 10.1053/jhep.2001.26513. View

17.

Ogata S, Belghiti J, Farges O, Varma D, Sibert A, Vilgrain V . Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br J Surg. 2006; 93(9):1091-8. DOI: 10.1002/bjs.5341. View

18.

Imamura H, Shimada R, Kubota M, Matsuyama Y, Nakayama A, Miyagawa S . Preoperative portal vein embolization: an audit of 84 patients. Hepatology. 1999; 29(4):1099-105. DOI: 10.1002/hep.510290415. View

19.

Sala S, Ardiles V, Ulla M, Alvarez F, Pekolj J, De Santibanes E . Our initial experience with ALPPS technique: encouraging results. Updates Surg. 2012; 64(3):167-72. DOI: 10.1007/s13304-012-0175-y. View

20.

Vennarecci G, Laurenzi A, Levi Sandri G, Busi Rizzi E, Cristofaro M, Montalbano M . The ALPPS procedure for hepatocellular carcinoma. Eur J Surg Oncol. 2014; 40(8):982-8. DOI: 10.1016/j.ejso.2014.04.002. View